Vertex Pharmaceuticals Incorporated (VIE:VRTX)
337.45
+2.80 (0.84%)
At close: Sep 12, 2025
Vertex Pharmaceuticals Market Cap
Vertex Pharmaceuticals has a market cap or net worth of €86.31 billion as of September 12, 2025. Its market cap has decreased by -22.62% in one year.
Market Cap
86.31B
Enterprise Value
77.35B
Revenue
9.72B
Ranking
n/a
PE Ratio
27.87
Stock Price
€337.45
Market Cap Chart
Since July 24, 1991, Vertex Pharmaceuticals's market cap has increased from 73.88M to 86.31B, an increase of 116,725.40%. That is a compound annual growth rate of 22.97%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 11, 2025 | 86.75B | -13.40% |
Dec 31, 2024 | 100.17B | 5.60% |
Dec 29, 2023 | 94.86B | 36.76% |
Dec 30, 2022 | 69.36B | 41.28% |
Dec 31, 2021 | 49.09B | -2.28% |
Dec 31, 2020 | 50.24B | 0.14% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Erste Group Bank AG | 32.14B |
VERBUND AG | 21.11B |
OMV Aktiengesellschaft | 15.24B |
Raiffeisen Bank International AG | 9.74B |
Strabag SE | 9.05B |
BAWAG Group AG | 8.83B |
Telekom Austria AG | 6.43B |
Andritz AG | 5.99B |